Lyxor 1 Financials
| E908 Etf | EUR 24.08 0.28 1.15% |
Lyxor |
The data published in Lyxor 1's official financial statements usually reflect Lyxor 1's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Lyxor 1. For example, before you start analyzing numbers published by Lyxor accountants, it's critical to develop an understanding of what Lyxor 1's liquidity, profitability, and earnings quality are in the context of the Commerz Funds Solutions SA space in which it operates.
Please note, the presentation of Lyxor 1's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Lyxor 1's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Lyxor 1's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Lyxor 1 . Please utilize our Beneish M Score to check the likelihood of Lyxor 1's management manipulating its earnings.
Lyxor 1 Etf Summary
Lyxor 1 competes with Lyxor BofAML, and Lyxor Index. COMSTAGE 1 is traded on Frankfurt Stock Exchange in Germany.| Instrument | Germany Etf |
| Exchange | Frankfurt Exchange |
| ISIN | DE000ETF9082 |
| Region | Others |
| Investment Issuer | Others |
| Etf Family | Commerz Funds Solutions SA |
| Benchmark | NYSE Composite |
| Currency | EUR - Euro |
Lyxor Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Lyxor 1's current stock value. Our valuation model uses many indicators to compare Lyxor 1 value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Lyxor 1 competition to find correlations between indicators driving Lyxor 1's intrinsic value. More Info.Lyxor 1 is rated # 5 ETF in one year return as compared to similar ETFs. It is rated # 2 ETF in net asset as compared to similar ETFs making up about 12,967,638 of Net Asset per One Year Return. Comparative valuation analysis is a catch-all model that can be used if you cannot value Lyxor 1 by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Lyxor 1's Etf. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Lyxor 1's earnings, one of the primary drivers of an investment's value.Lyxor 1 Systematic Risk
Lyxor 1's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Lyxor 1 volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Lyxor 1 correlated with the market. If Beta is less than 0 Lyxor 1 generally moves in the opposite direction as compared to the market. If Lyxor 1 Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Lyxor 1 is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Lyxor 1 is generally in the same direction as the market. If Beta > 1 Lyxor 1 moves generally in the same direction as, but more than the movement of the benchmark.
About Lyxor 1 Financials
What exactly are Lyxor 1 Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Lyxor 1's income statement, its balance sheet, and the statement of cash flows. Potential Lyxor 1 investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Lyxor 1 investors may use each financial statement separately, they are all related. The changes in Lyxor 1's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Lyxor 1's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Lyxor 1 Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Lyxor 1 is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Lyxor has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Lyxor 1's financials are consistent with your investment objective using the following steps:- Review Lyxor 1's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Lyxor 1's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Lyxor 1's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Lyxor 1's stock is overvalued or undervalued.
Lyxor 1 May 2, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Lyxor 1 help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Lyxor 1 . We use our internally-developed statistical techniques to arrive at the intrinsic value of Lyxor 1 based on widely used predictive technical indicators. In general, we focus on analyzing Lyxor Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Lyxor 1's daily price indicators and compare them against related drivers.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 3.64 | |||
| Value At Risk | (1.54) | |||
| Potential Upside | 1.5 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Lyxor 1 . Also, note that the market value of any etf could be tightly coupled with the direction of predictive economic indicators such as signals in nation. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.